Pneumolysin with low hemolytic activity confers an early growth advantage to Streptococcus pneumoniae in the blood

Area of Science:

• Microbiology and Immunology
• Infectious Diseases
• Vaccine Development

Background:

• Streptococcus pneumoniae causes severe diseases like pneumonia and meningitis.
• Pneumolysin (Ply) is a key virulence factor and a potential vaccine target.
• Emerging Ply variants with reduced hemolytic activity are linked to invasive disease outbreaks.

Purpose of the Study:

• To compare the virulence of wild-type S. pneumoniae with Ply-deficient and Ply allelic-replacement mutants.
• To investigate the protective immunogenicity of Ply against pneumococci with varying hemolytic activities.

Main Methods:

• Generation of Ply-deficient and ply4496 allelic-replacement derivatives of S. pneumoniae D39.
• Comparison of bacterial loads in blood between wild-type, mutant, and Ply4496-expressing strains.
• Assessment of protective immunity induced by Ply immunization against different hemolytic activity strains.

Main Results:

• The ply4496 allele caused a minor reduction in virulence but Ply-expressing strains remained more virulent than Ply-deficient ones.
• Ply4496-expressing strains showed superior growth in blood during early post-challenge, outperforming the wild type.
• Ply immunization conferred protection irrespective of the challenge strain's hemolytic activity.

Conclusions:

• Low-hemolytic-activity Ply alleles contribute to systemic virulence and offer a survival advantage in the bloodstream.
• Pneumococci expressing these reduced-hemolytic Ply variants are still susceptible to Ply-targeted vaccines.
• Ply-based vaccines represent a viable strategy against diverse S. pneumoniae strains, including those with altered virulence factors.